# PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)

> **NCT04066621** · PHASE4 · COMPLETED · sponsor: **Xiangbei Welman Pharmaceutical Co., Ltd** · enrollment: 30 (actual)

## Conditions studied

- Respiratory Tract Infections
- Urinary Tract Infections in Children

## Interventions

- **DRUG:** Ceftriaxone Sodium and Sulbactam Sodium for Injection

## Key facts

- **NCT ID:** NCT04066621
- **Lead sponsor:** Xiangbei Welman Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-28
- **Primary completion:** 2016-06-11
- **Final completion:** 2017-05-27
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066621, "PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04066621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*